Αρχική World News FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer... World News FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations Από Ogkologos - 25 Ιουλίου, 2025 381 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Spring Budget 2023: What does it mean for the mission to... 15 Μαρτίου, 2023 FDA Approves Capivasertib with Fulvestrant for Breast Cancer 23 Νοεμβρίου, 2023 FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf for HER2-positive Breast... 2 Ιουλίου, 2020 Teenage (…and young adult) kicks 5 Απριλίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Helicobacter Pylori Infection Modifies the Risk of Gastric Cancer Associated with... Rationale Explained for Granting EMA Authorisation for Extended Use of Nivolumab... ¿Qué son los biosimilares para el tratamiento del cáncer? Evaluating Targeted Therapy for People With Advanced Gastric or Gastroesophageal Junction...